Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - TAX PROVISION
Tax Provision PRPH - ProPhase Labs, Inc.
-6.02 M
LAST VALUE
-149.34%
2 YEAR CAGR
-126.36%
5 YEAR CAGR
-87.88%
10 YEAR CAGR